2024 Q1 Form 10-K Financial Statement

#000095017024030760 Filed on March 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $15.61M $235.9M $893.2M
YoY Change -92.05% 12.69% -54.17%
Cost Of Revenue $14.34M $206.9M $731.3M
YoY Change -90.9% 15.0% -57.09%
Gross Profit $1.274M $29.05M $161.9M
YoY Change -96.72% -1.4% -33.84%
Gross Profit Margin 8.16% 12.31% 18.13%
Selling, General & Admin $32.08M $77.58M $340.7M
YoY Change -66.77% -14.52% -39.85%
% of Gross Profit 2517.66% 267.08% 210.35%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $7.626M $11.06M $43.48M
YoY Change -28.31% 3.3% 12.32%
% of Gross Profit 598.59% 38.06% 26.85%
Operating Expenses $42.38M $88.50M $383.4M
YoY Change -56.1% -12.65% -32.3%
Operating Profit -$41.10M -$59.46M -$221.5M
YoY Change -39.79% -17.26% -61.26%
Interest Expense $14.34M -$9.741M -$24.29M
YoY Change 44.57% 70.77% -159.68%
% of Operating Profit
Other Income/Expense, Net -$43.27M -$108.3M
YoY Change 165.72% 150.78%
Pretax Income -$44.24M -$141.6M -$364.9M
YoY Change -40.83% -621.25% -22.62%
Income Tax $436.0K -$303.0K $615.0K
% Of Pretax Income
Net Earnings -$67.62M -$141.3M -$365.5M
YoY Change -9.9% -670.65% -19.11%
Net Earnings / Revenue -433.05% -59.9% -40.92%
Basic Earnings Per Share -$37.68 -$209.70
Diluted Earnings Per Share -$37.68 -$80.51 -$209.70
COMMON SHARES
Basic Shares Outstanding 1.795M 139.8M 1.743M
Diluted Shares Outstanding 1.794M 1.743M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $90.99M $135.6M $135.6M
YoY Change -71.27% -66.01% -66.01%
Cash & Equivalents $94.00M $135.6M $135.6M
Short-Term Investments
Other Short-Term Assets $124.1M $124.1M
YoY Change -5.55% -5.55%
Inventory $163.3M $163.3M
Prepaid Expenses
Receivables $9.139M $9.139M
Other Receivables $520.5M $520.5M
Total Short-Term Assets $105.1M $952.6M $952.6M
YoY Change -88.04% -21.92% -21.92%
LONG-TERM ASSETS
Property, Plant & Equipment $2.414M $31.20M $31.20M
YoY Change -95.31% -37.86% -57.71%
Goodwill $0.00
YoY Change
Intangibles $125.1M $131.9M
YoY Change -17.76% -17.0%
Long-Term Investments
YoY Change
Other Assets $67.66M $23.53M $23.53M
YoY Change 179.97% -9.53% -9.53%
Total Long-Term Assets $1.117B $522.8M $522.8M
YoY Change 44.58% 31.05% 31.05%
TOTAL ASSETS
Total Short-Term Assets $105.1M $952.6M $952.6M
Total Long-Term Assets $1.117B $522.8M $522.8M
Total Assets $1.222B $1.475B $1.475B
YoY Change -26.0% -8.87% -8.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.76M $26.76M
YoY Change -22.88% -22.88%
Accrued Expenses $24.12M $40.35M $40.35M
YoY Change -58.76% -47.46% -26.59%
Deferred Revenue $14.03M
YoY Change 31.63%
Short-Term Debt $516.3M $0.00 $0.00
YoY Change
Long-Term Debt Due $323.6M $323.6M
YoY Change 585.0% -0.2%
Total Short-Term Liabilities $541.5M $856.8M $856.8M
YoY Change -17.72% 21.82% 21.82%
LONG-TERM LIABILITIES
Long-Term Debt $548.1M $454.2M $454.2M
YoY Change -1.17% 12.94% 12.94%
Other Long-Term Liabilities $71.14M $42.29M $42.29M
YoY Change 286.99% 132.59% 10.39%
Total Long-Term Liabilities $619.3M $496.5M $496.5M
YoY Change 8.07% 18.11% 12.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $541.5M $856.8M $856.8M
Total Long-Term Liabilities $619.3M $496.5M $496.5M
Total Liabilities $1.161B $1.353B $1.353B
YoY Change -7.09% 18.32% 18.32%
SHAREHOLDERS EQUITY
Retained Earnings -$2.028B -$1.966B
YoY Change 21.04% 22.84%
Common Stock $2.090B $2.088B
YoY Change 0.57% 0.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $61.49M $122.2M $122.2M
YoY Change
Total Liabilities & Shareholders Equity $1.222B $1.475B $1.475B
YoY Change -26.0% -8.87% -8.87%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$67.62M -$141.3M -$365.5M
YoY Change -9.9% -670.65% -19.11%
Depreciation, Depletion And Amortization $7.626M $11.06M $43.48M
YoY Change -28.31% 3.3% 12.32%
Cash From Operating Activities $23.12M -$108.1M -$533.7M
YoY Change -127.2% 25.7% 389.33%
INVESTING ACTIVITIES
Capital Expenditures $644.0K $3.252M $14.81M
YoY Change -87.6% -23.77% -38.91%
Acquisitions
YoY Change
Other Investing Activities $41.72M $38.96M $188.0M
YoY Change -19.8% 82.73% -234.28%
Cash From Investing Activities $41.07M $35.71M $173.2M
YoY Change -12.28% 109.36% -205.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.399M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -132.5M -7.918M 97.34M
YoY Change 193.82% -87.44% -120.73%
NET CHANGE
Cash From Operating Activities 23.12M -108.1M -533.7M
Cash From Investing Activities 41.07M 35.71M 173.2M
Cash From Financing Activities -132.5M -7.918M 97.34M
Net Change In Cash -68.31M -80.26M -263.2M
YoY Change -17.99% -39.18% -64.57%
FREE CASH FLOW
Cash From Operating Activities $23.12M -$108.1M -$533.7M
Capital Expenditures $644.0K $3.252M $14.81M
Free Cash Flow $22.48M -$111.3M -$548.5M
YoY Change -124.92% 23.36% 311.47%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001580864
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-1112566
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Asset Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationAssetLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense
CY2022 us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Asset Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationAssetLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-39315
CY2023 dei Entity Registrant Name
EntityRegistrantName
VROOM, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
3600 W Sam Houston Pkwy S
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Floor 4
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77042
CY2023 dei City Area Code
CityAreaCode
518
CY2023 dei Local Phone Number
LocalPhoneNumber
535-9125
CY2023 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2023 dei Trading Symbol
TradingSymbol
VRM
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
184000000
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1794797
CY2023 dei Auditor Firm
AuditorFirmId
238
CY2023 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2023 dei Auditor Location
AuditorLocation
New York, New York
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
135585000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
398915000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
73234000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
73095000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
11200000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
21500000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9139000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13967000
CY2023Q4 vrm Finance Receivables At Fair Value Current
FinanceReceivablesAtFairValueCurrent
12501000
CY2022Q4 vrm Finance Receivables At Fair Value Current
FinanceReceivablesAtFairValueCurrent
12939000
CY2023Q4 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
503546000
CY2022Q4 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
321626000
CY2023Q4 us-gaap Inventory Net
InventoryNet
163250000
CY2022Q4 us-gaap Inventory Net
InventoryNet
320648000
CY2023Q4 vrm Beneficial Interests In Securitizations
BeneficialInterestsInSecuritizations
4485000
CY2022Q4 vrm Beneficial Interests In Securitizations
BeneficialInterestsInSecuritizations
20592000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
50899000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
58327000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
952639000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1220109000
CY2023Q4 vrm Finance Receivables At Fair Value Noncurrent
FinanceReceivablesAtFairValueNoncurrent
336169000
CY2022Q4 vrm Finance Receivables At Fair Value Noncurrent
FinanceReceivablesAtFairValueNoncurrent
140235000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24132000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50201000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
131892000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
158910000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7063000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23568000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23527000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
26004000
CY2023Q4 us-gaap Assets
Assets
1475422000
CY2022Q4 us-gaap Assets
Assets
1619027000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
26762000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
34702000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
52452000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
76795000
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
151178000
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
276988000
CY2023Q4 vrm Warehouse Credit Facilities Current
WarehouseCreditFacilitiesCurrent
421268000
CY2022Q4 vrm Warehouse Credit Facilities Current
WarehouseCreditFacilitiesCurrent
229518000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
172410000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
47239000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
14025000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10655000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8737000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9730000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9974000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
17693000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
856806000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
703320000
CY2023Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
454173000
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
402154000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
25183000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20129000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17109000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
18183000
CY2023Q4 us-gaap Liabilities
Liabilities
1353271000
CY2022Q4 us-gaap Liabilities
Liabilities
1143786000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1791286
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1791286
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1727525
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1727525
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2088381000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2075931000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1966232000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1600692000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
122151000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
475241000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1475422000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1619027000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
893203000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1948901000
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
731256000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1704114000
CY2023 us-gaap Gross Profit
GrossProfit
161947000
CY2022 us-gaap Gross Profit
GrossProfit
244787000
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
340657000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
566387000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
42769000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
38290000
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
48748000
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
211873000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-270227000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-571763000
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
37878000
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
164684000
CY2023 us-gaap Interest Expense
InterestExpense
45445000
CY2022 us-gaap Interest Expense
InterestExpense
40693000
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
21158000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
19363000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-108289000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-43181000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-364925000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-471590000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
615000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-19680000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-365540000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-451910000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-209.7
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-209.7
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-262.15
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-262.15
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1743128
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1743128
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1723843
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1723843
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
915194000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11957000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-451910000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
475241000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10051000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-365540000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
122151000
CY2023 us-gaap Profit Loss
ProfitLoss
-365540000
CY2022 us-gaap Profit Loss
ProfitLoss
-451910000
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
48748000
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
211873000
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
37878000
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
164684000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
43476000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
38707000
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4598000
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4809000
CY2022 us-gaap Gain Loss On Securitization Of Financial Assets
GainLossOnSecuritizationOfFinancialAssets
45589000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-23855000
CY2023 vrm Loss On Finance Receivables And Securitization Debt Net
LossOnFinanceReceivablesAndSecuritizationDebtNet
114702000
CY2022 vrm Loss On Finance Receivables And Securitization Debt Net
LossOnFinanceReceivablesAndSecuritizationDebtNet
66839000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
10051000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
11957000
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
-2360000
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
1812000
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4074000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
13406000
CY2023 vrm Provision To Record Finance Receivables Held For Sale At Lower Of Cost Or Fair Value
ProvisionToRecordFinanceReceivablesHeldForSaleAtLowerOfCostOrFairValue
20566000
CY2022 vrm Provision To Record Finance Receivables Held For Sale At Lower Of Cost Or Fair Value
ProvisionToRecordFinanceReceivablesHeldForSaleAtLowerOfCostOrFairValue
6541000
CY2023 vrm Amortization Of Unearned Discounts On Finance Receivables At Fair Value
AmortizationOfUnearnedDiscountsOnFinanceReceivablesAtFairValue
-25954000
CY2022 vrm Amortization Of Unearned Discounts On Finance Receivables At Fair Value
AmortizationOfUnearnedDiscountsOnFinanceReceivablesAtFairValue
-14593000
CY2023 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
17393000
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
7512000
CY2023 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
582170000
CY2022 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
625575000
CY2023 vrm Increase Decrease In Principal Payments Received On Finance Receivables Held For Sale
IncreaseDecreaseInPrincipalPaymentsReceivedOnFinanceReceivablesHeldForSale
105858000
CY2022 vrm Increase Decrease In Principal Payments Received On Finance Receivables Held For Sale
IncreaseDecreaseInPrincipalPaymentsReceivedOnFinanceReceivablesHeldForSale
64521000
CY2022 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
509612000
CY2023 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1606000
CY2022 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
7701000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-754000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-78060000
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-159758000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-403924000
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-22711000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4146000
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3266000
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2546000
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7940000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-24281000
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-24766000
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-53553000
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3370000
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-65148000
CY2023 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-10009000
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-38325000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-533684000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-109065000
CY2023 us-gaap Payments To Acquire Finance Receivables
PaymentsToAcquireFinanceReceivables
3392000
CY2022 us-gaap Payments To Acquire Finance Receivables
PaymentsToAcquireFinanceReceivables
56484000
CY2023 vrm Principal Payments Received On Finance Receivables At Fair Value
PrincipalPaymentsReceivedOnFinanceReceivablesAtFairValue
-174748000
CY2022 vrm Principal Payments Received On Finance Receivables At Fair Value
PrincipalPaymentsReceivedOnFinanceReceivablesAtFairValue
-132391000
CY2022 us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
43262000
CY2023 vrm Proceeds From Consolidation Of Variable Interest Entity
ProceedsFromConsolidationOfVariableInterestEntity
11409000
CY2023 vrm Principal Payments Received On Beneficial Interests
PrincipalPaymentsReceivedOnBeneficialInterests
-5193000
CY2022 vrm Principal Payments Received On Beneficial Interests
PrincipalPaymentsReceivedOnBeneficialInterests
-8341000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14805000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24234000
CY2022 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
47900000
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
267488000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
173153000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-164212000
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2399000
CY2023 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
261991000
CY2023 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
208476000
CY2022 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
192839000
CY2023 vrm Proceeds From Financing Of Beneficial Interests In Securitizations
ProceedsFromFinancingOfBeneficialInterestsInSecuritizations
24506000
CY2023 vrm Principal Repayments Of Financing Of Beneficial Interests In Securitizations
PrincipalRepaymentsOfFinancingOfBeneficialInterestsInSecuritizations
8698000
CY2023 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
559331000
CY2022 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1403042000
CY2023 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
685141000
CY2022 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1638855000
CY2023 vrm Proceeds From Warehouse Credit Facilities Of Consolidated Variable Interest Entities
ProceedsFromWarehouseCreditFacilitiesOfConsolidatedVariableInterestEntities
480100000
CY2022 vrm Proceeds From Warehouse Credit Facilities Of Consolidated Variable Interest Entities
ProceedsFromWarehouseCreditFacilitiesOfConsolidatedVariableInterestEntities
520800000
CY2023 vrm Repayments Of Warehouse Credit Facilities Of Consolidated Variable Interest Entities
RepaymentsOfWarehouseCreditFacilitiesOfConsolidatedVariableInterestEntities
290483000
CY2022 vrm Repayments Of Warehouse Credit Facilities Of Consolidated Variable Interest Entities
RepaymentsOfWarehouseCreditFacilitiesOfConsolidatedVariableInterestEntities
467216000
CY2023 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
36536000
CY2022 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
90208000
CY2023 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1653000
CY2022 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-4212000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
97340000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-469488000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-263191000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-742765000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
472010000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1214775000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
208819000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
472010000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
59351000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
34907000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5363000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2409000
CY2023 vrm Finance Receivables From Consolidation Of Two Thousand And Twenty Two Two Securitization Transaction
FinanceReceivablesFromConsolidationOfTwoThousandAndTwentyTwoTwoSecuritizationTransaction
180706000
CY2023 vrm Elimination Of Beneficial Interest From The Consolidation Of Two Thousand And Twenty Two Two Securitization Transaction
EliminationOfBeneficialInterestFromTheConsolidationOfTwoThousandAndTwentyTwoTwoSecuritizationTransaction
9811000
CY2023 vrm Securitization Debt From Consolidation Of Two Thousand And Twenty Two Two Securitization Transaction
SecuritizationDebtFromConsolidationOfTwoThousandAndTwentyTwoTwoSecuritizationTransaction
186386000
CY2023 vrm Reclassification Of Finance Receivables Held For Sale To Finance Receivables At Fair Value Net
ReclassificationOfFinanceReceivablesHeldForSaleToFinanceReceivablesAtFairValueNet
248081000
CY2022 vrm Fair Value Of Beneficial Interests Received In Securitization Transactions
FairValueOfBeneficialInterestsReceivedInSecuritizationTransactions
30082000
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2023 vrm Long Lived Asset Impairment Charges
LongLivedAssetImpairmentCharges
47400000
CY2023 vrm Operating Lease Impairment Loss Related To Wind Down Of Ecommerce Operations
OperatingLeaseImpairmentLossRelatedToWindDownOfEcommerceOperations
22200000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;"> </span></p><p style="text-indent:6.773%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">The preparation of consolidated financial statements in accordance with U.S. GAAP requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue, expenses and related disclosures. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to income taxes, the realizability of inventory, stock-based compensation, contingencies, revenue-related reserves, fair value measurements and useful lives of property and equipment and intangible assets. The Company bases its estimates on historical experience, market conditions, and on various other assumptions that are believed to be reasonable. Actual results may differ from these estimates.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;"> </span></p>
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
11200000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
21500000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
8500000
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4100000
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
14400000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
13400000
CY2023Q4 vrm Financing Receivable Held For Sale Valuation Allowances
FinancingReceivableHeldForSaleValuationAllowances
33800000
CY2022Q4 vrm Financing Receivable Held For Sale Valuation Allowances
FinancingReceivableHeldForSaleValuationAllowances
10500000
CY2023 vrm Business Combination Measurement Period
BusinessCombinationMeasurementPeriod
P1Y
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Concentration of Credit Risk and Significant Customers</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;"> </span></p><p style="text-indent:6.773%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">The Company’s principal financial instruments subject to potential concentration of credit risk are cash and cash equivalents and accounts receivable, which are unsecured. The Company’s cash balances are maintained at various large, reputable financial institutions. Deposits held with financial institutions may at times exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and, therefore, management believes they bear minimal risk. The Company’s cash equivalents primarily consist of money market funds that hold investments in highly liquid U.S. government securities. Concentration of credit risk with respect to accounts receivable is generally mitigated by a large customer base.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;"> </span></p><p style="text-indent:6.773%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;"> </span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">For the years ended December 31, 2023 and 2022, no customer represented 10% or more of the Company’s revenues and no customer represented more than 10% of the Company’s accounts receivable as of December 31, 2023 and 2022</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">.</span>
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
135600000
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
73200000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
94000000
CY2023Q4 vrm Outstanding Borrowings Percentage
OutstandingBorrowingsPercentage
0.40
CY2023 vrm Payment For Severance Related Benefits
PaymentForSeveranceRelatedBenefits
16500000
CY2023 vrm Payment For Early Contract And Lease Termination Costs
PaymentForEarlyContractAndLeaseTerminationCosts
15000000
CY2023Q4 vrm Reserve For Chargebacks
ReserveForChargebacks
6200000
CY2022Q4 vrm Reserve For Chargebacks
ReserveForChargebacks
8200000
CY2023Q4 vrm Cumulative Profit Sharing Payment Recognized
CumulativeProfitSharingPaymentRecognized
20600000
CY2022Q4 vrm Cumulative Profit Sharing Payment Recognized
CumulativeProfitSharingPaymentRecognized
22500000
CY2023 us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2023 vrm Proforma Adjustments Related To Non Recurring Acquisition Related Cost
ProformaAdjustmentsRelatedToNonRecurringAcquisitionRelatedCost
5700000
CY2022 vrm Non Recurring Tax Adjustment Benefit
NonRecurringTaxAdjustmentBenefit
24100000
CY2023Q4 vrm Vehicles
Vehicles
162659000
CY2022Q4 vrm Vehicles
Vehicles
317994000
CY2023Q4 vrm Parts And Accessories
PartsAndAccessories
591000
CY2022Q4 vrm Parts And Accessories
PartsAndAccessories
2654000
CY2023Q4 us-gaap Inventory Net
InventoryNet
163250000
CY2022Q4 us-gaap Inventory Net
InventoryNet
320648000
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
21800000
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
24200000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
42328000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
83104000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18196000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
32903000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24132000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
50201000
CY2023 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
700000
CY2022 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
400000
CY2021Q4 us-gaap Goodwill
Goodwill
158817000
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
42886000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
201703000
CY2022Q4 us-gaap Goodwill
Goodwill
0
CY2023Q4 us-gaap Goodwill
Goodwill
0
CY2022Q4 us-gaap Goodwill
Goodwill
0
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
201700000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
190300000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
58408000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
131892000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
190300000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
31390000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
158910000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27000000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
25300000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
27022000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
27022000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
21979000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
21882000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive
21882000
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive
12105000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
131892000
CY2023Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
3694000
CY2022Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
2093000
CY2023Q4 vrm Accrued Vehicle Related Expenses Current
AccruedVehicleRelatedExpensesCurrent
9655000
CY2022Q4 vrm Accrued Vehicle Related Expenses Current
AccruedVehicleRelatedExpensesCurrent
14789000
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
4398000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
5983000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
13223000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
28276000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2935000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3488000
CY2023Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
6050000
CY2022Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
7383000
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
5708000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
3990000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6789000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
10793000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
52452000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
76795000
CY2023Q4 vrm Vehicle Payable Current
VehiclePayableCurrent
3522000
CY2022Q4 vrm Vehicle Payable Current
VehiclePayableCurrent
3617000
CY2023Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
1594000
CY2022Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
3919000
CY2023Q4 vrm Insurance Payable Current
InsurancePayableCurrent
4158000
CY2022Q4 vrm Insurance Payable Current
InsurancePayableCurrent
4551000
CY2023Q4 vrm Other Current
OtherCurrent
700000
CY2022Q4 vrm Other Current
OtherCurrent
5606000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9974000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
17693000
CY2023Q4 vrm Lessee Operating Lease Lease Not Yet Commenced Lease Liability Payments Due
LesseeOperatingLeaseLeaseNotYetCommencedLeaseLiabilityPaymentsDue
1200000
CY2023Q4 vrm Lessee Operating Lease Lease Not Yet Commenced Lease Commencement Period
LesseeOperatingLeaseLeaseNotYetCommencedLeaseCommencementPeriod
P12M
CY2023Q4 us-gaap Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1
LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
P7Y
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y1M6D
CY2023Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.071
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y2M12D
CY2022Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.058
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
8951000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
8402000
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
312000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
690000
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
4125000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
3810000
CY2023 us-gaap Sublease Income
SubleaseIncome
379000
CY2022 us-gaap Sublease Income
SubleaseIncome
72000
CY2023 us-gaap Lease Cost
LeaseCost
13009000
CY2022 us-gaap Lease Cost
LeaseCost
12830000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
11892000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
9322000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13260000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
19896000
CY2023 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
23500000
CY2023 vrm Operating Lease Impairment Loss Related To Wind Down Of Ecommerce Operations
OperatingLeaseImpairmentLossRelatedToWindDownOfEcommerceOperations
22200000
CY2023 vrm Operating Lease Impairment Loss Related To Closing Of Physical Office Location
OperatingLeaseImpairmentLossRelatedToClosingOfPhysicalOfficeLocation
1300000
CY2022 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
6500000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
10744000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6960000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
6233000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5877000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
4873000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
6329000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
41016000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
7096000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
33920000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8737000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
25183000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
33920000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
172410000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
47239000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
454173000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
402154000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
626583000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
449393000
CY2022Q4 vrm Debt Instrument Initial Principal Amount
DebtInstrumentInitialPrincipalAmount
93730000
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
82556000
CY2022Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
79829000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
147600000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
91800000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
47800000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
26800000
CY2023Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
4100000
CY2003Q3 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust Noncurrent
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrustNoncurrent
10000000
CY2023Q4 us-gaap Debt Instrument Convertible Threshold Consecutive Trading Days1
DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
30
CY2023Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
1
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
every 80 shares of common stock became one of common stock
CY2023 us-gaap Common Stock Voting Rights
CommonStockVotingRights
one vote
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
137647
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
35715
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
475.74
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M25D
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
3281
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
336.8
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
6346
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
387.49
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
26088
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
514.72
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M20D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
16494
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
378.4
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y8M15D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
16861
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
468.68
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y8M12D
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2022Q2 vrm Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Fair Value Of Common Stock
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValueOfCommonStock
91.2
CY2022Q2 vrm Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Fair Value Of Common Stock
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValueOfCommonStock
66.4
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0278
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0305
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
108268
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
259.37
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
110365
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
73.1
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
20278
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
468.31
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
23089
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
213.51
CY2023Q4 vrm Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingNumber
175266
CY2023Q4 vrm Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageGrantDateFairValue
124.33
CY2023Q4 vrm Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableNumber
1152
CY2023Q4 vrm Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExercisableWeightedAverageGrantDateFairValue
84.8
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
174114
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
124.59
CY2022 us-gaap Restructuring Charges
RestructuringCharges
15025000
us-gaap Restructuring Charges
RestructuringCharges
21728000
CY2023 us-gaap Fair Value Assets And Liabilities Measured On Recurring Basis Gain Loss Included In Earnings
FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings
68429000
CY2022 us-gaap Fair Value Assets And Liabilities Measured On Recurring Basis Gain Loss Included In Earnings
FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings
34277000
CY2023Q4 vrm Finance Receivables Marked To Fair Value On Non Recurring Basis
FinanceReceivablesMarkedToFairValueOnNonRecurringBasis
34800000
CY2022Q4 vrm Finance Receivables Marked To Fair Value On Non Recurring Basis
FinanceReceivablesMarkedToFairValueOnNonRecurringBasis
22400000
CY2023Q1 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
275
CY2023Q4 us-gaap Restructuring And Related Cost Expected Cost1
RestructuringAndRelatedCostExpectedCost1
4100000
CY2023Q2 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
120
CY2023Q2 us-gaap Restructuring And Related Cost Expected Cost1
RestructuringAndRelatedCostExpectedCost1
2300000
CY2023 us-gaap Severance Costs1
SeveranceCosts1
6703000
CY2022 us-gaap Severance Costs1
SeveranceCosts1
7358000
us-gaap Severance Costs1
SeveranceCosts1
14061000
CY2022 vrm Impairment Of Operating Lease Right Of Use Assets
ImpairmentOfOperatingLeaseRightOfUseAssets
6491000
vrm Impairment Of Operating Lease Right Of Use Assets
ImpairmentOfOperatingLeaseRightOfUseAssets
6491000
CY2022 us-gaap Other Restructuring Costs
OtherRestructuringCosts
1176000
us-gaap Other Restructuring Costs
OtherRestructuringCosts
1176000
CY2023 us-gaap Restructuring Charges
RestructuringCharges
6703000
CY2022 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
7941000
CY2022 us-gaap Payments For Restructuring
PaymentsForRestructuring
7131000
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
810000
CY2023 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
6703000
CY2023 us-gaap Payments For Restructuring
PaymentsForRestructuring
7440000
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
73000
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2023Q4 vrm Segment Assets
SegmentAssets
0
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
893203000
CY2023 us-gaap Gross Profit
GrossProfit
161947000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1948901000
CY2022 us-gaap Gross Profit
GrossProfit
244787000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
893203000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1948901000
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
340657000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
566387000
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
42769000
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
38290000
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
48748000
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
211873000
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
37878000
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
164684000
CY2023 us-gaap Interest Expense
InterestExpense
45445000
CY2022 us-gaap Interest Expense
InterestExpense
40693000
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
21158000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
19363000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-108289000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-43181000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-364925000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-471590000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-365520000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-472203000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
595000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
613000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-364925000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-471590000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
526000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4083000
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
89000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
92000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
615000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
4175000
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-20472000
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-3383000
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-23855000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
615000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-19680000
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0017
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0417
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-76657000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-99034000
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-23718000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-3529000
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-36000
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-129000
CY2023 vrm Income Tax Rate Reconciliation Permanent Differences
IncomeTaxRateReconciliationPermanentDifferences
1550000
CY2022 vrm Income Tax Rate Reconciliation Permanent Differences
IncomeTaxRateReconciliationPermanentDifferences
1510000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
0
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
41241000
CY2023 vrm Effective Income Tax Rate Reconcilliation Deferred Tax Adjustment For Acquisition Of Business
EffectiveIncomeTaxRateReconcilliationDeferredTaxAdjustmentForAcquisitionOfBusiness
0
CY2022 vrm Effective Income Tax Rate Reconcilliation Deferred Tax Adjustment For Acquisition Of Business
EffectiveIncomeTaxRateReconcilliationDeferredTaxAdjustmentForAcquisitionOfBusiness
-23855000
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
99926000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
66634000
CY2023 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-450000
CY2022 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-2518000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
615000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-19680000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
358700000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
258800000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
216000000
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
365841000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
265927000
CY2023Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
9758000
CY2022Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
9395000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
2169000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
3067000
CY2023Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
3729000
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
0
CY2023Q4 vrm Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
8829000
CY2022Q4 vrm Deferred Tax Assets Leasing Arrangements
DeferredTaxAssetsLeasingArrangements
7086000
CY2023Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
3636000
CY2022Q4 us-gaap Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross
DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
10549000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
1765000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
8342000
CY2023Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2441000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2612000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
398168000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
306978000
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
358722000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
258796000
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
39446000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
48182000
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
32687000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
37377000
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
0
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
3017000
CY2023Q4 vrm Deferred Tax Liabilities Repossession Expenses
DeferredTaxLiabilitiesRepossessionExpenses
4966000
CY2022Q4 vrm Deferred Tax Liabilities Repossession Expenses
DeferredTaxLiabilitiesRepossessionExpenses
2194000
CY2023Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
1793000
CY2022Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
5594000
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
39446000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
48182000
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
0
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-365540000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-451910000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1743128
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1743128
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1723843
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1723843
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-209.7
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-209.7
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-262.15
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-262.15
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
266184
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
225618
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
true
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
true
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
true
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
true

Files In Submission

Name View Source Status
0000950170-24-030760-index-headers.html Edgar Link pending
0000950170-24-030760-index.html Edgar Link pending
0000950170-24-030760.txt Edgar Link pending
0000950170-24-030760-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img229078759_0.jpg Edgar Link pending
img230002280_0.jpg Edgar Link pending
img230925801_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrm-20231231.htm Edgar Link pending
vrm-20231231.xsd Edgar Link pending
vrm-ex10_15.htm Edgar Link pending
vrm-ex10_18.htm Edgar Link pending
vrm-ex10_19.htm Edgar Link pending
vrm-ex10_25.htm Edgar Link pending
vrm-ex10_26.htm Edgar Link pending
vrm-ex10_27.htm Edgar Link pending
vrm-ex21_1.htm Edgar Link pending
vrm-ex23_1.htm Edgar Link pending
vrm-ex31_1.htm Edgar Link pending
vrm-ex31_2.htm Edgar Link pending
vrm-ex32_1.htm Edgar Link pending
vrm-ex32_2.htm Edgar Link pending
vrm-ex97_1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
vrm-20231231_htm.xml Edgar Link completed